Pages that link to "Q28478765"
Jump to navigation
Jump to search
The following pages link to Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial (Q28478765):
Displaying 50 items.
- Response to peripheral immune stimulation within the brain: magnetic resonance imaging perspective of treatment success (Q26782095) (← links)
- New insights into the impact of neuro-inflammation in rheumatoid arthritis (Q27023946) (← links)
- Treatment of primary Sjögren syndrome (Q30249011) (← links)
- The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder (Q33578766) (← links)
- The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer (Q33727960) (← links)
- Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. (Q34028408) (← links)
- Neurobiological studies of fatigue (Q34290841) (← links)
- A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. (Q34333249) (← links)
- The representation of inflammatory signals in the brain - a model for subjective fatigue in multiple sclerosis (Q34677503) (← links)
- Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses (Q35059951) (← links)
- Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives (Q35133812) (← links)
- An expanding role for interleukin-1 blockade from gout to cancer (Q35219001) (← links)
- Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome? (Q35774612) (← links)
- Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial (Q36126508) (← links)
- Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. (Q36335752) (← links)
- Heat shock proteins and chronic fatigue in primary Sjögren's syndrome (Q36719483) (← links)
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases (Q36816872) (← links)
- Chronic fatigue in patients with unexplained self-reported food hypersensitivity and irritable bowel syndrome: validation of a Norwegian translation of the Fatigue Impact Scale (Q36996557) (← links)
- Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad? (Q37221851) (← links)
- Interleukin-1 as a mediator of fatigue in disease: a narrative review (Q37597282) (← links)
- Treating inflammation by blocking interleukin-1 in humans (Q37636664) (← links)
- Targeting IL-1 in Sjögren's syndrome. (Q38074174) (← links)
- Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions. (Q38076460) (← links)
- Macrophages: important players in primary Sjögren's syndrome? (Q38197286) (← links)
- Classification criteria and treatment modalities in primary Sjögren's syndrome (Q38197287) (← links)
- Biologic treatment in Sjögren's syndrome. (Q38262453) (← links)
- Fatigue in psoriasis: a phenomenon to be explored (Q38306698) (← links)
- Recurrent Fevers for the Pediatric Immunologist: It's Not All Immunodeficiency (Q38680309) (← links)
- Safety of treatments for primary Sjögren's syndrome (Q38711144) (← links)
- Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects (Q38795404) (← links)
- Present and future of biologic drugs in primary Sjögren's syndrome (Q38822415) (← links)
- Inflammation and the Silent Sequelae of Stroke (Q38871034) (← links)
- Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain (Q38889818) (← links)
- Innate immunity in Sjögren's syndrome. (Q39232871) (← links)
- A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study (Q39356677) (← links)
- Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment (Q40069331) (← links)
- Metabolic syndrome in Sjögren's syndrome patients: a relevant concern for clinical monitoring (Q40540065) (← links)
- Patient burden of Sjögren's: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity (Q41687111) (← links)
- Association of brain functional magnetic resonance activity with response to tumor necrosis factor inhibition in rheumatoid arthritis (Q43538492) (← links)
- Impact of double positive for anti-centromere and anti-SS-a/Ro antibodies on clinicopathological characteristics of primary Sjögren's syndrome: a retrospective cohort study (Q47292941) (← links)
- Management of primary Sjögren's syndrome: recent developments and new classification criteria (Q47700923) (← links)
- Microglia and CNS Interleukin-1: Beyond Immunological Concepts (Q49798820) (← links)
- The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome (Q55970269) (← links)
- Anakinra Therapy for Non-cancer Inflammatory Diseases (Q59136398) (← links)
- Primary Sjögren's Syndrome: Fatigue Is an Ever-Present, Fluctuating, and Uncontrollable Lack of Energy (Q59243174) (← links)
- Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjögren’s syndrome (Q64052682) (← links)
- Managing fatigue in patients with primary Sjögren's syndrome: challenges and solutions (Q64094947) (← links)
- Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study (Q64106266) (← links)
- Heat-shock protein 90α in plasma reflects severity of fatigue in patients with Crohn's disease (Q90634291) (← links)
- Salivary IL-1ß as an Objective Measure for Fatigue in Multiple Sclerosis? (Q90650061) (← links)